| 翻訳と辞書 |
| Accredo Health Inc. ： ウィキペディア英語版 |
Accredo
Accredo is a specialty pharmaceutical and service provider for patients with complex and chronic health conditions. Accredo provides specialty drugs, drugs that cost more than $600 per month, with the average being $10,000 a month, which treat serious conditions such as multiple sclerosis, rheumatoid arthritis, hemophilia and cancer.〔 It is a wholly owned subsidiary of Express Scripts and is headquartered in Memphis.
==History==
Southern Health Systems (SHS), Accredo's predecessor, was founded in 1983. SHS distributed Protropin, a human growth hormone, and clotting factor.〔 Accredo Health, Inc. was organized in 1996. The following year it acquired Southern Health Systems, Inc. (SHS) and its wholly owned subsidiary, Nova Factor, Inc. (NFI). Soon thereafter, Accredo acquired Hemophilia Health Services (HHS). In 1999, Accredo filed its IPO and became a public company, trading on NASDAQ under the ticker ACDO.〔(【引用サイトリンク】publisher=NASDAQ )〕 In 2004, Medco Health Solutions Inc. allied with Accredo Health to form a specialty pharmacy. In June of that year, its wholly owned subsidiary, HHS acquired Hemophilia Resources of America. In August the following year, Medco acquired Accredo and it became a wholly owned subsidiary of the company.〔 In 2012, Express Scripts acquired Medco, making Accredo a wholly owned subsidiary of Express Scripts. As a result, Accredo merged with CuraScript SP Specialty Pharmacy, operating under the name Accredo.〔
Accredo offers over 300 specialty drugs which are offered in 30 pharmacies nationwide.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Accredo」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|